DENOSUMAB VERSUS ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH METASTATIC BONE DISEASE: SUBGROUP ANALYSES BY BASELINE CHARACTERISTICS

被引：0
|
作者：
Stopeck, A. [1 ]
Lipton, A. [2 ]
Fizazi, K. [3 ]
Smith, M. R. [4 ,5 ]
Shore, N. D. [6 ]
Martin, M. [7 ]
Vadhan-Raj, S. [8 ]
Zhou, K. [9 ]
Balakumaran, A. [9 ]
Braun, A. H. [9 ]
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Penn State Hershey Med Ctr, Hershey, PA USA
[3] Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[4] Massachusetts Gen Hosp, Ctr Canc, Dept Hematol, Boston, MA USA
[5] Massachusetts Gen Hosp, Ctr Canc, Dept Oncol, Boston, MA USA
[6] Atlantic Urol Clin, Carolina Urol Res Ctr, Myrtle Beach, SC USA
[7] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[8] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Sect Cytokines & Support Oncol, Houston, TX 77030 USA
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] Effect of denosumab versus zoledronic acid (ZA) in preventing skeletal-related events (SREs) in patients with metastatic bone disease: Subgroup analyses by baseline characteristics.
    Lipton, Allan
    Fizazi, Karim
    Stopeck, Alison
    Henry, David H.
    Smith, Matthew Raymond
    Shore, Neal D.
    Martin, Miguel
    Vadhan-Raj, Saroj
    Zhou, Kefei
    Balakumaran, Arun
    Braun, Ada H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
    Lipton, A.
    Fizazi, K.
    Stopeck, A. T.
    Henry, D. H.
    Smith, M. R.
    Shore, N.
    Martin, M.
    Vadhan-Raj, S.
    Brown, J. E.
    Richardson, G. E.
    Saad, F.
    Yardley, D. A.
    Zhou, K.
    Balakumaran, A.
    Braun, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 53 : 75 - 83
  • [3] Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic
    Cristino, Joaquim
    Finek, Jindrich
    Jandova, Petra
    Kolek, Martin
    Pasztor, Balint
    Giannopoulou, Christina
    Qian, Yi
    Brezina, Tomas
    Lothgren, Mickael
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (08) : 799 - 812
  • [4] A COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN BREAST CANCER PATIENTS WITH BONE METASTASES
    Fujiwara, Yasuhiro
    Stopeck, Alison
    de Boer, Richard
    Lichinitser, Mikhail
    Tonkin, Katia
    Yardley, Denise
    Fan, Michelle
    Jiang, Qi
    Jun, Susie
    Dansey, Roger
    Braun, Ada
    ANNALS OF ONCOLOGY, 2010, 21 : 12 - 12
  • [5] A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases
    Stopeck, A.
    de Boer, R.
    Fujiwara, Y.
    Lichinitser, M.
    Tonkin, K.
    Yardley, D.
    Fan, M.
    Jiang, Q.
    Jun, S.
    Dansey, R.
    Braun, A.
    CANCER RESEARCH, 2009, 69 (24) : 490S - 490S
  • [6] Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma
    Jeon, Ha-Lim
    Oh, In-Sun
    Baek, Yeon-Hee
    Yang, Hyowon
    Park, Jeehye
    Hong, Soojung
    Shin, Ju-Young
    JOURNAL OF BONE AND MINERAL METABOLISM, 2020, 38 (02) : 254 - 263
  • [7] Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma
    Ha-Lim Jeon
    In-Sun Oh
    Yeon-Hee Baek
    Hyowon Yang
    Jeehye Park
    Soojung Hong
    Ju-Young Shin
    Journal of Bone and Mineral Metabolism, 2020, 38 : 254 - 263
  • [8] The skeletal-related events of denosumab versus zoledronic acid in patients with bone metastases: A meta-analysis of randomized controlled trials
    Zhang, Zhicai
    Pu, Feifei
    Shao, Zengwu
    JOURNAL OF BONE ONCOLOGY, 2017, 9 : 21 - 24
  • [9] COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
    Bell, M. J.
    Miller, J. D.
    Namjoshi, M.
    Russell, M. W.
    VALUE IN HEALTH, 2011, 14 (03) : A159 - A159
  • [10] The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
    Widyadharma, I. Putu Eka
    Tertia, Clarissa
    Vania, Aurelia
    Tiffani, Pamela
    Wiratnaya, I. Gede Eka
    POSTEPY PSYCHIATRII I NEUROLOGII, 2024, 33 (03): : 172 - 177
12345